Journals / Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi / 2026 / Cilt: 6 Sayı: Ek Sayı 2

Tuberous Sclerosis Complex and Epilepsy

Tuberoskleroz Kompleksi ve Epilepsi

Senem Ayça(MANİSA CELÂL BAYAR ÜNİVERSİTESİ)0000-0001-7486-9655
Pages
8–10
Publication Date
2026-03-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A predictive and preventive approach may help both to delay seizure onset and to improve seizure response.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Tuberous Sclerosis Complex (TSC) is a rare genetic disorder associated with mutations in the TSC1 or TSC2 genes, which lead to hyperactivation of the mTOR signaling pathway.
📊
Key Findings & Data:These genes encode proteins that form an inhibitory complex for RHEB (Ras homolog enriched in brain); therefore, hyperactivation of mTORC1 (mechanistic target of rapamycin complex 1) constitutes a fundamental feature of the disease (1,2). mTORC1 signaling plays a central role in the cellular and molecular mechanisms underlying epileptogenesis and developmental epileptic encephalopathy.
💡
Conclusion & Impact:A predictive and preventive approach may help both to delay seizure onset and to improve seizure response.
🔬Design:Derleme
📍Scope:Comprehensive Sample
⚙️Variables:Tüberoskleroz kompleksi · epilepsi · mTORC1

Abstract

Introduction: Tuberous Sclerosis Complex (TSC) is a rare genetic disorder associated with mutations in the TSC1 or TSC2 genes, which lead to hyperactivation of the mTOR signaling pathway. These genes encode proteins that form an inhibitory complex for RHEB (Ras homolog enriched in brain); therefore, hyperactivation of mTORC1 (mechanistic target of rapamycin complex 1) constitutes a fundamental feature of the disease (1,2). mTORC1 signaling plays a central role in the cellular and molecular mechanisms underlying epileptogenesis and developmental epileptic encephalopathy. Conclusion: Advances in understanding the mechanisms of epileptogenesis have led to the emergence of new concepts in the management of epilepsy associated with TSC. A predictive and preventive approach may help both to delay seizure onset and to improve seizure response.

Özet

Giriş: Tüberoskleroz kompleksi (TSK), mTOR kompleksinin aşırı aktivasyonuna neden olan TSC1 veya TSC2 genlerindeki mutasyonlarla ilişkili nadir bir genetik hastalıktır. Bu genler, RHEB (beyinde zenginleştirilmiş Ras homologu) için bir inhibitör kompleks oluşturan proteinleri kodlar, bu nedenle mTORC1 (rapamisin kompleksi 1'in memeli hedefi) hiperaktivasyonu hastalığın temel özelliğini oluşturur (1,2). Epileptojenik süreç ve gelişimsel epileptik ensefalopatinin altında yatan hücresel ve moleküler mekanizmalarda mTORC1 sinyal iletimi merkezi bir rol oynar. Sonuç: Epileptogenezin altında yatan mekanizmalara ilişkin ilerlemeler, TSK ile ilişkili epilepsinin yönetiminde yeni kavramların ortaya çıkmasına yol açmıştır. Öngörücü ve önleyici bir yaklaşım hem nöbet başlangıcını geciktirmeye hem de nöbet yanıtını iyileştirmeye yardımcı olabilir.

🔖

Cite This Article

Ayça, S. (2026). Tuberous Sclerosis Complex and Epilepsy. Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 6 Sayı: Ek Sayı 2, 8–10. https://ajindex.com/articles/1647685

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, Frost MD, Fuchs Z, Gosnell ES, Gupta N, Jansen AC, Jóźwiak S, Kingswood JC, Knilans TK, McCormack FX, Pounders A, Roberds SL, Rodriguez-Buritica DF, Roth J, Sampson JR, Sparagana S, Thiele EA, Weiner HL, Wheless JW, Towbin AJ, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021 Oct;123:50-66. doi: 10.1016/j.pediatrneurol.2021.07.011. Epub 2021 Jul 24. PMID: 34399110.
  2. Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J. Molecular neurobiology of mTOR. Neuroscience. 2017 Jan 26;341:112-153. doi: 10.1016/j.neuroscience.2016.11.017. Epub 2016 Nov 23. PMID: 27889578.
  3. Eichmüller OL, Corsini NS, Vértesy Á, Morassut I, Scholl T, Gruber VE, Peer AM, Chu J, Novatchkova M, Hainfellner JA, Paredes MF, Feucht M, Knoblich JA. Amplification of human interneuron progenitors promotes brain tumors and neurological defects. Science. 2022 Jan 28;375(6579):eabf5546. doi: 10.1126/science.abf5546. Epub 2022 Jan 28. PMID: 35084981; PMCID: PMC7613689.
  4. Zou J, Zhang B, Gutmann DH, Wong M. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner. Epilepsia. 2017 Dec;58(12):2053-2063. doi: 10.1111/epi.13923. Epub 2017 Oct 12. PMID: 29023667; PMCID: PMC5716871.
  5. Zhang B, Zou J, Han L, Beeler B, Friedman JL, Griffin E, Piao YS, Rensing NR, Wong M. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex. Epilepsia. 2018 Sep;59(9):1796-1806. doi: 10.1111/epi.14526. Epub 2018 Aug 5. PMID: 30079598; PMCID: PMC6121723.
  6. Jeong A, Nakagawa JA, Wong M. Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex. J Child Neurol. 2017 Dec;32(14):1092-1098. doi: 10.1177/0883073817737446. PMID: 29129154; PMCID: PMC5773119.
  7. Pressler RM, Cilio MR, Mizrahi EM, Moshé SL, Nunes ML, Plouin P, Vanhatalo S, Yozawitz E, de Vries LS, Puthenveettil Vinayan K, Triki CC, Wilmshurst JM, Yamamoto H, Zuberi SM. The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia. 2021 Mar;62(3):615-628. doi: 10.1111/epi.16815. Epub 2021 Feb 1. PMID: 33522601.
  8. Avanzini, G.S., G.; Canafoglia, L.; Franceschetti, S., Maturation of cortical physiological properties relevant to epileptogenesis, in Abnormal cortical development and epilepsy, R.A. Spreafico, G.; Andermann, F.; editors, Editor. 1999, John-Libbey and Company: London. p. 63-75.
  9. Curatolo P, Specchio N, Aronica E. Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy. Lancet Neurol. 2022 Sep;21(9):843-856. doi: 10.1016/S1474-4422(22)00213-7. PMID: 35963265.
  10. Hulshof, H. M., Slot, E. M. H., EPISTOP Consortium, Lequin, M., Breuillard, D., Boddaert, N., Jozwiak, S., Kotulska, K., Riney, K., Feucht, M., Samueli, S., Scholl, T., Krsek, P., Benova, B., Braun, K. P. J., Jansen, F. E., & Nabbout, R. (2021). Fetal brain magnetic resonance imaging findings predict neurodevelopment in children with tuberous sclerosis complex. Journal of Pediatrics, 233, 156-162.e2. https://doi.org/10.1016/j.jpeds.2021.02.060
  11. De Ridder J, Verhelle B, Vervisch J, Lemmens K, Kotulska K, Moavero R, Curatolo P, Weschke B, Riney K, Feucht M, Krsek P, Nabbout R, Jansen AC, Wojdan K, Domanska-Pakieła D, Kaczorowska-Frontczak M, Hertzberg C, Ferrier CH, Samueli S, Benova B, Aronica E, Kwiatkowski DJ, Jansen FE, Jóźwiak S, Lagae L; EPISTOP consortium. Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes. Epilepsia. 2021 May;62(5):1208-1219. doi: 10.1111/epi.16892. Epub 2021 Mar 29. PMID: 33778971.
  12. Kotulska K, Kwiatkowski DJ, Curatolo P, Weschke B, Riney K, Jansen F, Feucht M, Krsek P, Nabbout R, Jansen AC, Wojdan K, Sijko K, Głowacka-Walas J, Borkowska J, Sadowski K, Domańska-Pakieła D, Moavero R, Hertzberg C, Hulshof H, Scholl T, Benova B, Aronica E, de Ridder J, Lagae L, Jóźwiak S; EPISTOP Investigators. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial. Ann Neurol. 2021 Feb;89(2):304-314. doi: 10.1002/ana.25956. Epub 2020 Nov 27. PMID: 33180985; PMCID: PMC7898885.
  13. French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Berkowitz N, Voi M, Peyrard S, Pelov D, Franz DN. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016 Oct 29;388(10056):2153-2163. doi: 10.1016/S0140-6736(16)31419-2. Epub 2016 Sep 6. PMID: 27613521.
  14. Thiele EA, Bebin EM, Bhathal H, Jansen FE, Kotulska K, Lawson JA, O'Callaghan FJ, Wong M, Sahebkar F, Checketts D, Knappertz V; GWPCARE6 Study Group. Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial. JAMA Neurol. 2021 Mar 1;78(3):285-292. doi: 10.1001/jamaneurol.2020.4607. PMID: 33346789; PMCID: PMC7754080.
  15. Słowińska M, Kotulska K, Szymańska S, Roberds SL, Fladrowski C, Jóźwiak S. Approach to Preventive Epilepsy Treatment in Tuberous Sclerosis Complex and Current Clinical Practice in 23 Countries. Pediatr Neurol. 2021 Feb;115:21-27. doi: 10.1016/j.pediatrneurol.2020.11.003. Epub 2020 Nov 5. PMID: 33310533.
  16. Tong X, Wang X, Qin L, Zhou J, Guan Y, Teng P, Wang J, Yang Y, Li T, Luan G. Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex. Epilepsy Behav. 2022 Jan;126:108431. doi: 10.1016/j.yebeh.2021.108431. Epub 2021 Dec 6. PMID: 34883463.
  17. Fang Y, Li D, Wang M, Zhao X, Duan J, Gu Q, Li B, Zha J, Mei D, Bian G, Zhang M, Zhang H, Hu J, Yang L, Yu L, Li H, Liao J. Ketogenic diet therapy for drug-resistant epilepsy and cognitive impairment in children with tuberous sclerosis complex. Front Neurol. 2022;13:863826. doi:10.3389/fneur.2022.863826.
  18. Liu S, Yu T, Guan Y, Zhang K, Ding P, Chen L, Shan Y, Guo Q, Liu Q, Yao Y, Yang M, Zhang S, Lin Y, Zhao R, Mao Z, Zhang J, Zhang C, Zhang R, Yang Z, Qian R, Li Y, Zhang G, Yuan L, Yang W, Tian H, Zhang H, Li W, Zhang X, Yin J, Guo Y, Zou L, Qin J, Fang F, Wang X, Ge M, Liang S. Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China. Brain. 2020 Feb 1;143(2):570-581. doi: 10.1093/brain/awz411. PMID: 31953931.
  19. Vannicola C, Tassi L, Barba C, Boniver C, Cossu M, de Curtis M, De Palma L, D'Errico I, Didato G, Guerrini R, La Briola F, Luisi C, Mai R, Mari F, Marras C, Mastrangelo M, Peron A, Specchio N, Toldo I, Turner K, Vignoli A, Canevini MP. Seizure outcome after epilepsy surgery in tuberous sclerosis complex: Results and analysis of predictors from a multicenter study. J Neurol Sci. 2021 Aug 15;427:117506. doi: 10.1016/j.jns.2021.117506. Epub 2021 May 21. PMID: 34087568.